MIRA Pharmaceuticals (MIRA) Institutional Ownership $1.26 -0.14 (-9.96%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for MIRA Pharmaceuticals (NASDAQ:MIRA)CurrentInstitutional OwnershipPercentage35.16%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$614.23KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$22.75K Get MIRA Insider Trade Alerts Want to know when executives and insiders are buying or selling MIRA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MIRA Institutional Buying and Selling by Quarter Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. MIRA Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/23/2024 Cross Staff Investments Inc365,901$476K0.4%-4.6%2.475% 10/21/2024 Suncoast Equity Management90,000$117K0.0%+125.0%0.609% 5/20/2024Virtu Financial LLC63,055$69K0.0%+330.2%0.427% 5/2/2024 Suncoast Equity Management40,000$44K0.0%N/A0.271% 5/2/2024 Cross Staff Investments Inc383,401$422K0.4%N/A2.594% 4/10/2024 Praetorian Wealth Management Inc.27,500$30K0.0%N/A0.186% (Data available from 1/1/2016 forward) MIRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIRA shares? During the previous two years, the following institutional investors and hedge funds held shares of MIRA Pharmaceuticals shares: Cross Staff Investments Inc ($476K), Suncoast Equity Management ($117K), and Virtu Financial LLC ($69K), Praetorian Wealth Management Inc. ($30K).Learn more on MIRA's institutional investors. What percentage of MIRA Pharmaceuticals stock is owned by institutional investors? 35.16% of MIRA Pharmaceuticals stock is owned by institutional investors. Learn more on MIRA's institutional investor holdings. Which institutional investors have been buying MIRA Pharmaceuticals stock? The following institutional investors have purchased MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($383.40K), Suncoast Equity Management ($90K), Virtu Financial LLC ($48.40K), and Praetorian Wealth Management Inc. ($27.50K). How much institutional buying is happening at MIRA Pharmaceuticals? Institutional investors have bought a total of 549,298 shares in the last 24 months. This purchase volume represents approximately $614.23K in transactions. Which MIRA Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($17.50K). How much institutional selling is happening at MIRA Pharmaceuticals? Institutional investors have sold a total of 17,500 shares in the last 24 months. This volume of shares sold represents approximately $22.75K in transactions. Related Companies Oramed Pharmaceuticals Institutional Ownership Adagene Institutional Ownership Invivyd Institutional Ownership SELLAS Life Sciences Group Institutional Ownership Genenta Science Institutional Ownership Relmada Therapeutics Institutional Ownership Annovis Bio Institutional Ownership PowerUp Acquisition Institutional Ownership Eupraxia Pharmaceuticals Institutional Ownership Genelux Institutional Ownership This page (NASDAQ:MIRA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.